Redefining Migraine Prevention: Early Treatment With Anti-CGRP Monoclonal Antibodies Enhances Response
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Neurology, Neurosurgery, and Psychiatry
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world
J. Neurol. Neurosurg. Psychiatr. 2024 May 22;[EPub Ahead of Print], E Caronna, VJ Gallardo, G Egeo, MM Vázquez, CN Castellanos, JA Membrilla, G Vaghi, J Rodríguez-Montolio, N Fabregat Fabra, F Sánchez-Caballero, A Jaimes Sánchez, A Muñoz-Vendrell, R Oliveira, G Gárate, Y González-Osorio, D Guisado-Alonso, R Ornello, C Thunstedt, I Fernández-Lázaro, M Torres-Ferrús, A Alpuente, P Torelli, C Aurilia, RL Pére, MJR Castrillo, R Icco, G Sances, S Broadhurst, HC Ong, AG García, S Campoy, J Sanahuja, G Cabral, I Beltrán Blasco, M Waliszewska-Prosół, L Pereira, A Layos-Romero, I Luzeiro, L Dorado, MR Álvarez Escudero, A May, A López-Bravo, IP Martins, C Sundal, P Irimia, A Lozano Ros, AB Gago-Veiga, FV Juanes, R Ruscheweyh, S Sacco, E Cuadrado-Godia, D García-Azorín, J Pascual, R Gil-Gouveia, M Huerta-Villanueva, J Rodriguez-Vico, J Viguera Romero, V Obach, S Santos-Lasaosa, M Ghadiri-Sani, C Tassorelli, J Díaz-de-Terán, S Díaz Insa, CG Oria, P Barbanti, P Pozo-RosichFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.